Osteogenic potential of mesenchymal stem cells of epicardial adipose tissue in patients with coronary heart disease
Authors:
- E. G. UchasovaEUE. G. Uchasova
- Yu. A. DylevaYDYu. A. Dyleva
- T. A. SlesarevaTST. A. Slesareva
- E. V. BelikEBE. V. Belik
- A. V. PonasenkoAPA. V. Ponasenko
- E. A. VelikanovaEVE. A. Velikanova
- V. G. MatveevaVMV. G. Matveeva
- I. V. DvadtsatovIDI. V. Dvadtsatov
- O. L. TarasovaOTO. L. Tarasova
- O. V. GruzdevaOGO. V. Gruzdeva
Open Access
- 16 April 2025
- journal article
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 24 (1) , 86-95
Abstract
Aim. To assess the osteogenic potential of mesenchymal stem cells (MSCs) of epicardial adipose tissue (EAT) in patients with stable coronary heart disease based on obtaining gene profiles (osteogenesis markers). Materials and methods. In EAT MSCs, the expression levels of the RUNX2 (RUNX transcription factor encoding gene), BGLAP (osteocalcin encoding gene), SPP1 (osteopontin encoding gene), SP7 (Osterix encoding gene) genes were determined using real-time polymerase chain reaction (PCR). Using immunofluorescence staining, the amount of RUNX2, osteocalcin, osteopontin, and Osterix proteins was determined in the supernatant of cultured MSCs. Results. It was found that the expression of RUNX2 in cells cultured in a medium with osteoinducers was 1.88 times higher than in undifferentiated MSCs (p = 0.012). The level of RUNX2 protein was also higher in a differentiated cell culture (p < 0.05). Similar results were obtained regarding the level of SPP1 mRNA expression (p = 0.012). BGLAP expression did not differ between differentiated and undifferentiated MSC cultures. The level of SP7 gene expression did not differ in cells either with or without an osteoblastic medium. It is worth noting that using immunofluorescence staining, there were no differences detected in the expression of Osterix and OCN between cultures of differentiated and undifferentiated cells. Conclusion. It was found that EAT MSCs have osteogenic potential, which was manifested by the expression of osteogenesis genes in both differentiated and undifferentiated MSCs. The increase in the expression level of SSP1 and RUNX2 mRNA on the 15th day of cultivation with osteoblastic medium indicates that the studied cells are preosteoblasts and are at the stage of extracellular matrix synthesis.Keywords
This publication has 20 references indexed in Scilit:
- Establishing a deeper understanding of the osteogenic differentiation of monolayer cultured human pluripotent stem cells using novel and detailed analysesStem Cell Research & Therapy, 2021
- Expression of RUNX2 and Osterix in Rat Mesenchymal Stem Cells during Culturing in Osteogenic-Conditioned MediumBulletin of Experimental Biology and Medicine, 2020
- Osteopontin in Bone Metabolism and Bone DiseasesMedical Science Monitor, 2020
- Stem cells from human cardiac adipose tissue depots show different gene expression and functional capacitiesStem Cell Research & Therapy, 2019
- The Emerging Role of Mesenchymal Stem Cells in Vascular CalcificationStem Cells International, 2019
- New insights into the biology of osteocalcinBone, 2016
- Dlx5 and Mef2 Regulate a Novel Runx2 Enhancer for Osteoblast-Specific ExpressionJournal of Bone and Mineral Research, 2014
- Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT)Cytotherapy, 2013
- Genetic and molecular control of osterix in skeletal formationJournal of Cellular Biochemistry, 2012
- Emerging Role of Circulating Calcifying Cells in the Bone-Vascular AxisCirculation, 2012